Liu Yidan, Liu Xiuxing, Lv Jianjie, Zhang Qi, Yang Zhenlan, Chen Xuhao, Gu Chenyang, Zhang Chun, Zhuo Yehong, Su Wenru
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou 510060, China.
Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Sci Adv. 2025 Jul 18;11(29):eadv6642. doi: 10.1126/sciadv.adv6642. Epub 2025 Jul 16.
Aging induces substantial structural and functional decline in the retina, yet the molecular drivers of this process remain elusive. In this study, we used heterochronic parabiosis (HP) combined with single-cell RNA sequencing to generate comprehensive transcriptomic profiles of murine retinas from young, aged, and HP pairs, aiming to identify antiaging targets. Our analysis revealed extensive transcriptional alterations across retinal cell types with aging. HP experiments demonstrated that systemic factors from young mice rejuvenated aged retinas and alleviated senescent phenotypes, while aged blood accelerated aging in young mice. Integrative analysis pinpointed adiponectin receptor 1 (AdipoR1) and the downstream adenosine 5'-monophosphate-activated protein kinase (AMPK) signaling pathway as central to the molecular mechanisms underlying retinal rejuvenation. Treatment with the AdipoR1 agonist AdipoRon reversed retinal aging. Mechanistically, AdipoR1-AMPK activation promoted mitochondrial function, contributing to the restoration of youthful cellular phenotypes. Together, our study identifies AdipoR1 as a therapeutic target for retinal aging and provides insights into the molecular programs driving retinal rejuvenation.
衰老会导致视网膜出现显著的结构和功能衰退,然而这一过程的分子驱动因素仍不清楚。在本研究中,我们将异时联体共生(HP)与单细胞RNA测序相结合,以生成来自年轻、年老和HP联体小鼠视网膜的全面转录组图谱,旨在确定抗衰老靶点。我们的分析揭示了随着年龄增长,视网膜细胞类型中广泛的转录变化。HP实验表明,来自年轻小鼠的全身因子可使衰老的视网膜恢复活力并减轻衰老表型,而老年血液则加速了年轻小鼠的衰老。综合分析确定脂联素受体1(AdipoR1)和下游的5'-单磷酸腺苷激活蛋白激酶(AMPK)信号通路是视网膜恢复活力分子机制的核心。用AdipoR1激动剂AdipoRon治疗可逆转视网膜衰老。从机制上讲,AdipoR1-AMPK激活促进了线粒体功能,有助于恢复年轻的细胞表型。总之,我们的研究确定AdipoR1是视网膜衰老的治疗靶点,并为驱动视网膜恢复活力的分子程序提供了见解。